Analyst Expectations for Recursion Pharmaceuticals's Future - Recursion Pharmaceuticals (NASDAQ:RXRX)
Source: benzinga.com
📰 Recursion Pharmaceuticals News
Page 27 - Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $847,795.60 in Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 65,015 shares of the firm’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $13.04, for a total value of $847,795.60. Following the completion of the sale, the chief executive officer now directly […]
Christopher Gibson Recursion Pharmaceuticals Stock Performance Recursion Pharmaceuticals Inc Hedge Funds Weigh In On Recursion Pharmaceuticals Recursion Pharmaceuticals News Ratings For Recursion Pharmaceuticals Daily
Source: wkrb13.com
What's Cooking At Beyond Meat? Q2 Earnings On The Table After The Close - Beyond Meat (NASDAQ:BYND)
Beyond Meat Inc (NASDAQ: BYND) shares are trading lower Monday ahead of the company's quarterly results. Here's a look at what to expect from the plant-based meats company after the bell.
Source: benzinga.com
Nvidia Just Confirmed an Emerging AI Boom in Biotech
It takes about $900 million and 13.5 years to develop a new successful drug; but not for long. AI is turning that entire process on its head.
Recursion Pharmaceuticals Morgan Stanley Just Confirmed Takeda Pharmaceutical Deep Pharma Intelligence
Source: investorplace.com
AI is a shot in the arm for better medicine
AI will help researchers predict how drugs will interact, their toxicity, and potential inhibitions. New successful compounds will be identified more quickly and cost-effectively.
Source: foxnews.com
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 8%
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price dropped 8% during mid-day trading on Wednesday . The company traded as low as $12.64 and last traded at $12.70. Approximately 818,678 shares traded hands during trading, a decline of 73% from the average daily volume of 3,030,443 shares. The stock had previously closed at […]
Tina Marriott Larson Christopher Gibson Morgan Stanley News Ratings For Recursion Pharmaceuticals Daily Recursion Pharmaceuticals Insider Activity At Recursion Pharmaceuticals
Source: dailypolitical.com
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 8%
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) fell 8% during trading on Wednesday . The stock traded as low as $12.64 and last traded at $12.70. 818,678 shares were traded during mid-day trading, a decline of 73% from the average session volume of 3,030,443 shares. The stock had previously closed at $13.81. […]
Terry Ann Burrell Tina Marriott Larson Recursion Pharmaceuticals Stock Down Recursion Pharmaceuticals Morgan Stanley Recursion Pharmaceuticals Inc
Source: wkrb13.com
Confluent (CFLT) Q2 2023 Earnings Call Transcript
CFLT earnings call for the period ending June 30, 2023.
Source: fool.com
Confluent, Inc. (NASDAQ:CFLT) Q2 2023 Earnings Call Transcript
Confluent, Inc. (NASDAQ:CFLT) Q2 2023 Earnings Call Transcript August 2, 2023 Confluent, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $0.06. Operator: Hi, everyone. Welcome to the Confluent Q2 2023 Earnings Conference Call. I’m Shane Xie from Investor Relations, and I’m joined by Jay Kreps, Co-Founder and CEO; Steffan Tomlinson, CFO […]
Source: yahoo.com
2 Healthcare AI Stocks That Could Go Parabolic
Shares of Recursion Pharmaceuticals and GE Healthcare are both up sharply so far this year.
Peter Arduini Eli Lilly Ge Healthcare Centers For Medicare Recursion Pharmaceuticals Medicaid Services
Source: fool.com